TransMedics (TMDX) Shares Outstanding (Diluted Average) (2020 - 2024)

TransMedics has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $35.2 million in Q3 2024.

• For the quarter ending Q3 2024, Shares Outstanding (Diluted Average) rose 7.99% year-over-year to $35.2 million; the trailing twelve-month figure through Sep 2024 stood at $35.2 million (up 7.99% YoY), and the FY2023 full-year result was $32.5 million, up 10.02% from the prior year.
• Shares Outstanding (Diluted Average) for Q3 2024 stood at $35.2 million, up from $35.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $35.2 million in Q3 2024, with the low at $21.2 million in Q1 2020.
• Average Shares Outstanding (Diluted Average) over 5 years is $29.0 million, with a median of $28.0 million recorded in 2022.
• Year-over-year, Shares Outstanding (Diluted Average) gained 28.96% in 2021 and increased 1.25% in 2022.
• Tracing TMDX's Shares Outstanding (Diluted Average) over 5 years: stood at $24.7 million in 2020, then gained by 11.8% to $27.6 million in 2021, then increased by 7.02% to $29.6 million in 2022, then rose by 10.02% to $32.5 million in 2023, then increased by 8.31% to $35.2 million in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $35.2 million (Q3 2024), $35.0 million (Q2 2024), and $34.7 million (Q1 2024), per Business Quant data.

Peer Comparison